Zhenrui Shi

1.2k total citations
47 papers, 898 citations indexed

About

Zhenrui Shi is a scholar working on Immunology, Dermatology and Rheumatology. According to data from OpenAlex, Zhenrui Shi has authored 47 papers receiving a total of 898 indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Immunology, 14 papers in Dermatology and 14 papers in Rheumatology. Recurrent topics in Zhenrui Shi's work include Psoriasis: Treatment and Pathogenesis (18 papers), Dermatology and Skin Diseases (14 papers) and Systemic Lupus Erythematosus Research (9 papers). Zhenrui Shi is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (18 papers), Dermatology and Skin Diseases (14 papers) and Systemic Lupus Erythematosus Research (9 papers). Zhenrui Shi collaborates with scholars based in China, United States and Taiwan. Zhenrui Shi's co-authors include Steven H. Itzkowitz, Xuesong Wu, Samuel Hwang, Liangchun Wang, Sebastian Yu, Guozhen Tan, Yu‐Jui Yvonne Wan, Yan Zhou, Dan Han and Mimi Nguyen and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Frontiers in Immunology and Journal of Investigative Dermatology.

In The Last Decade

Zhenrui Shi

45 papers receiving 884 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhenrui Shi China 16 414 242 195 182 158 47 898
An‐Fang Huang China 17 439 1.1× 283 1.2× 236 1.2× 99 0.5× 136 0.9× 57 930
Mika Nishihara Japan 7 522 1.3× 292 1.2× 124 0.6× 62 0.3× 246 1.6× 9 996
Jens Gerwien Denmark 17 448 1.1× 295 1.2× 110 0.6× 60 0.3× 173 1.1× 33 1.1k
Ruifang Wu China 14 447 1.1× 402 1.7× 120 0.6× 134 0.7× 132 0.8× 45 928
Christopher Chang United States 10 588 1.4× 263 1.1× 101 0.5× 164 0.9× 139 0.9× 12 925
Melissa Krystel‐Whittemore United States 7 394 1.0× 161 0.7× 71 0.4× 76 0.4× 97 0.6× 14 793
Takeru Yoshimura Japan 19 649 1.6× 329 1.4× 209 1.1× 95 0.5× 275 1.7× 36 1.7k
Jun‐ichi Kashiwakura Japan 19 801 1.9× 221 0.9× 274 1.4× 62 0.3× 128 0.8× 65 1.2k
Mineko Tsuruoka Japan 6 482 1.2× 238 1.0× 108 0.6× 58 0.3× 215 1.4× 7 916
Claus Haase Denmark 20 485 1.2× 201 0.8× 107 0.5× 76 0.4× 101 0.6× 32 897

Countries citing papers authored by Zhenrui Shi

Since Specialization
Citations

This map shows the geographic impact of Zhenrui Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhenrui Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhenrui Shi more than expected).

Fields of papers citing papers by Zhenrui Shi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhenrui Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhenrui Shi. The network helps show where Zhenrui Shi may publish in the future.

Co-authorship network of co-authors of Zhenrui Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Zhenrui Shi. A scholar is included among the top collaborators of Zhenrui Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhenrui Shi. Zhenrui Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xiong, Hui, et al.. (2025). Metabolic regulation of the immune cell in psoriasis: mechanisms and interventions. Current Opinion in Immunology. 96. 102614–102614.
2.
Schimelman, Jacob, et al.. (2025). 3D printed nerve guidance conduit for biologics‐free nerve regeneration and vascular integration. Bioengineering & Translational Medicine. 10(6). e70057–e70057.
3.
Wu, Xuesong, Xiuting Liu, Yanyun Jiang, et al.. (2024). Topical treatment of tyrosine kinase 2 inhibitor through borneol-embedded hydrogel: Evaluation for preventive, therapeutic, and Recurrent management of psoriasis. Bioactive Materials. 41. 83–95. 8 indexed citations
4.
Shi, Zhenrui, Tomotaka Mabuchi, Xuesong Wu, et al.. (2023). The Chemokine, CCL20, and Its Receptor, CCR6, in the Pathogenesis and Treatment of Psoriasis and Psoriatic Arthritis. PubMed. 8(3). 107–117. 2 indexed citations
5.
Zhang, Jing, et al.. (2023). Hyper- and Hypo-pigmented Small Macules on Face, Neck and Extremities: A Quiz. Acta Dermato Venereologica. 103. adv00848–adv00848. 1 indexed citations
6.
Wu, Xuesong, et al.. (2023). Impact of Gut Bacterial Metabolites on Psoriasis and Psoriatic Arthritis: Current Status and Future Perspectives. Journal of Investigative Dermatology. 143(9). 1657–1666. 5 indexed citations
7.
Yamada, Daisuke, Simon Vu, Xuesong Wu, et al.. (2022). Gain-of-function of TRPM4 predisposes mice to psoriasiform dermatitis. Frontiers in Immunology. 13. 1025499–1025499. 6 indexed citations
8.
Liu, Xiuting, Zhenrui Shi, Si‐Yao Lu, et al.. (2022). Enhanced Migratory Ability of Neutrophils Toward Epidermis Contributes to the Development of Psoriasis via Crosstalk With Keratinocytes by Releasing IL-17A. Frontiers in Immunology. 13. 817040–817040. 17 indexed citations
9.
Yan, Di, Andrew Blauvelt, Amit K. Dey, et al.. (2021). New Frontiers in Psoriatic Disease Research, Part II: Comorbidities and Targeted Therapies. Journal of Investigative Dermatology. 141(10). 2328–2337. 22 indexed citations
10.
Shi, Zhenrui, Xuesong Wu, Clarissa Santos Rocha, et al.. (2021). Short-Term Western Diet Intake Promotes IL-23‒Mediated Skin and Joint Inflammation Accompanied by Changes to the Gut Microbiota in Mice. Journal of Investigative Dermatology. 141(7). 1780–1791. 44 indexed citations
11.
Qiu, Xiaonan, Lin Zheng, Xiuting Liu, et al.. (2021). ULK1 Inhibition as a Targeted Therapeutic Strategy for Psoriasis by Regulating Keratinocytes and Their Crosstalk With Neutrophils. Frontiers in Immunology. 12. 714274–714274. 19 indexed citations
12.
Shi, Zhenrui, Xuesong Wu, Chun‐Yi Wu, et al.. (2021). Bile Acids Improve Psoriasiform Dermatitis through Inhibition of IL-17A Expression and CCL20-CCR6–Mediated Trafficking of T Cells. Journal of Investigative Dermatology. 142(5). 1381–1390.e11. 30 indexed citations
13.
Shi, Zhenrui, Xuesong Wu, Sebastian Yu, et al.. (2020). Short-Term Exposure to a Western Diet Induces Psoriasiform Dermatitis by Promoting Accumulation of IL-17A–Producing γδ T Cells. Journal of Investigative Dermatology. 140(9). 1815–1823. 50 indexed citations
14.
Shi, Zhenrui, Emma García-Melchor, Xuesong Wu, et al.. (2020). Differential Requirement for CCR6 in IL-23–Mediated Skin and Joint Inflammation. Journal of Investigative Dermatology. 140(12). 2386–2397. 9 indexed citations
15.
Wu, Xuesong, Rajinder Singh, Daniel K. Hsu, et al.. (2020). A Small Molecule CCR2 Antagonist Depletes Tumor Macrophages and Synergizes with Anti–PD-1 in a Murine Model of Cutaneous T-Cell Lymphoma (CTCL). Journal of Investigative Dermatology. 140(7). 1390–1400.e4. 31 indexed citations
16.
Shi, Zhenrui, Jing Yin, Yuping Zhang, et al.. (2020). The diagnostic benefit of antibodies against ribosomal proteins in systemic lupus erythematosus. Advances in Rheumatology. 60(1). 45–45. 6 indexed citations
17.
Wu, Xuesong, et al.. (2020). A monocyte-keratinocyte-derived co-culture assay accurately identifies efficacies of BET inhibitors as therapeutic candidates for psoriasiform dermatitis. Journal of Dermatological Science. 100(1). 31–38. 3 indexed citations
18.
Zhou, Yan, Dan Han, Xuesong Wu, et al.. (2019). Transient receptor potential ankyrin 1 (TRPA1) positively regulates imiquimod‐induced, psoriasiform dermal inflammation in mice. Journal of Cellular and Molecular Medicine. 23(7). 4819–4828. 38 indexed citations
19.
Wu, Xuesong, et al.. (2019). 693 BET inhibitor OTX015 reduces imiquimod-induced mouse psoriasiform dermatitis. Journal of Investigative Dermatology. 139(5). S119–S119. 1 indexed citations
20.
Shi, Zhenrui, David Tacha, & Steven H. Itzkowitz. (1994). Monoclonal antibody COL-1 reacts with restricted epitopes on carcinoembryonic antigen: an immunohistochemical study.. Journal of Histochemistry & Cytochemistry. 42(9). 1215–1219. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by An‐Fang Huang Breakdown of academic impact, for papers by Mika Nishihara Breakdown of academic impact, for papers by Jens Gerwien Breakdown of academic impact, for papers by Ruifang Wu Breakdown of academic impact, for papers by Christopher Chang Breakdown of academic impact, for papers by Melissa Krystel‐Whittemore Breakdown of academic impact, for papers by Takeru Yoshimura Breakdown of academic impact, for papers by Jun‐ichi Kashiwakura Breakdown of academic impact, for papers by Mineko Tsuruoka Breakdown of academic impact, for papers by Claus Haase
Rankless by CCL
2026